AAPL 10-Q: Smart Summary
Consolidated Statements of Operations
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||
| March 28, 2026 | March 29, 2025 | March 28, 2026 | March 29, 2025 | ||||||||||||||||||||
| Net sales: | |||||||||||||||||||||||
| Products | $ | 80,208 | $ | 68,714 | $ | 193,951 | $ | 166,674 | |||||||||||||||
| Services | 30,976 | 26,645 | 60,989 | 52,985 | |||||||||||||||||||
| Total net sales | 111,184 | 95,359 | 254,940 | 219,659 | |||||||||||||||||||
| Cost of sales: | |||||||||||||||||||||||
| Products | 49,179 | 44,030 | 116,657 | 103,477 | |||||||||||||||||||
| Services | 7,224 | 6,462 | 14,271 | 13,040 | |||||||||||||||||||
| Total cost of sales | 56,403 | 50,492 | 130,928 | 116,517 | |||||||||||||||||||
| Gross margin | 54,781 | 44,867 | 124,012 | 103,142 | |||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
| Research and development | 11,419 | 8,550 | 22,306 | 16,818 | |||||||||||||||||||
| Selling, general and administrative | 7,477 | 6,728 | 14,969 | 13,903 | |||||||||||||||||||
| Total operating expenses | 18,896 | 15,278 | 37,275 | 30,721 | |||||||||||||||||||
| Operating income | 35,885 | 29,589 | 86,737 | 72,421 | |||||||||||||||||||
| Other income/(expense), net | (52) | (279) | 98 | (527) | |||||||||||||||||||
| Income before provision for income taxes | 35,833 | 29,310 | 86,835 | 71,894 | |||||||||||||||||||
| Provision for income taxes | 6,255 | 4,530 | 15,160 | 10,784 | |||||||||||||||||||
| Net income | $ | 29,578 | $ | 24,780 | $ | 71,675 | $ | 61,110 | |||||||||||||||
| Earnings per share: | |||||||||||||||||||||||
| Basic | $ | 2.02 | $ | 1.65 | $ | 4.87 | $ | 4.06 | |||||||||||||||
| Diluted | $ | 2.01 | $ | 1.65 | $ | 4.85 | $ | 4.05 | |||||||||||||||
| Shares used in computing earnings per share: | |||||||||||||||||||||||
| Basic | 14,673,278 | 14,994,082 | 14,710,718 | 15,037,903 | |||||||||||||||||||
| Diluted | 14,725,873 | 15,056,133 | 14,768,115 | 15,103,499 | |||||||||||||||||||
Consolidated Balance Sheets
| March 28, 2026 | September 27, 2025 | ||||||||||
| ASSETS: | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 45,572 | $ | 35,934 | |||||||
| Marketable securities | 22,935 | 18,763 | |||||||||
| Accounts receivable, net | 30,339 | 39,777 | |||||||||
| Vendor non-trade receivables | 23,172 | 33,180 | |||||||||
| Inventories | 6,747 | 5,718 | |||||||||
| Other current assets | 15,349 | 14,585 | |||||||||
| Total current assets | 144,114 | 147,957 | |||||||||
| Non-current assets: | |||||||||||
| Marketable securities | 78,088 | 77,723 | |||||||||
| Property, plant and equipment, net | 50,116 | 49,834 | |||||||||
| Intangible assets, net | 21,334 | 11,093 | |||||||||
| Other non-current assets | 77,430 | 72,634 | |||||||||
| Total non-current assets | 226,968 | 211,284 | |||||||||
| Total assets | $ | 371,082 | $ | 359,241 | |||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY: | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | 57,349 | $ | 69,860 | |||||||
| Other current liabilities | 57,654 | 66,387 | |||||||||
| Deferred revenue | 9,331 | 9,055 | |||||||||
| Commercial paper | 1,997 | 7,979 | |||||||||
| Term debt | 8,310 | 12,350 | |||||||||
| Total current liabilities | 134,641 | 165,631 | |||||||||
| Non-current liabilities: | |||||||||||
| Term debt | 74,404 | 78,328 | |||||||||
| Other non-current liabilities | 55,546 | 41,549 | |||||||||
| Total non-current liabilities | 129,950 | 119,877 | |||||||||
| Total liabilities | 264,591 | 285,508 | |||||||||
| Commitments and contingencies | |||||||||||
| Shareholders’ equity: | |||||||||||
Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 14,667,688 and 14,773,260 shares issued and outstanding, respectively | 99,507 | 93,568 | |||||||||
| Retained earnings/(Accumulated deficit) | 12,359 | (14,264) | |||||||||
| Accumulated other comprehensive loss | (5,375) | (5,571) | |||||||||
| Total shareholders’ equity | 106,491 | 73,733 | |||||||||
| Total liabilities and shareholders’ equity | $ | 371,082 | $ | 359,241 | |||||||
Consolidated Statements of Cash Flows
| Six Months Ended | |||||||||||
| March 28, 2026 | March 29, 2025 | ||||||||||
Cash, cash equivalents, and restricted cash and cash equivalents, beginning balances | $ | 35,934 | $ | 29,943 | |||||||
| Operating activities: | |||||||||||
| Net income | 71,675 | 61,110 | |||||||||
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||||
| Depreciation and amortization | 6,653 | 5,741 | |||||||||
| Share-based compensation expense | 7,122 | 6,512 | |||||||||
| Other | (1,717) | (2,217) | |||||||||
| Changes in operating assets and liabilities: | |||||||||||
| Accounts receivable, net | 9,295 | 7,266 | |||||||||
| Vendor non-trade receivables | 10,008 | 9,171 | |||||||||
| Inventories | (1,084) | 858 | |||||||||
| Other current and non-current assets | (14,329) | (4,371) | |||||||||
| Accounts payable | (12,297) | (14,604) | |||||||||
| Other current and non-current liabilities | 7,301 | (15,579) | |||||||||
| Cash generated by operating activities | 82,627 | 53,887 | |||||||||
| Investing activities: | |||||||||||
| Purchases of marketable securities | (32,432) | (12,442) | |||||||||
| Proceeds from maturities of marketable securities | 18,691 | 26,587 | |||||||||
| Proceeds from sales of marketable securities | 8,615 | 5,210 | |||||||||
| Payments for acquisition of property, plant and equipment | (4,344) | (6,011) | |||||||||
| Other | (1,584) | (635) | |||||||||
| Cash generated by/(used in) investing activities | (11,054) | 12,709 | |||||||||
| Financing activities: | |||||||||||
| Payments for taxes related to net share settlement of equity awards | (3,252) | (3,205) | |||||||||
| Payments for dividends and dividend equivalents | (7,743) | (7,614) | |||||||||
| Repurchases of common stock | (36,989) | (49,504) | |||||||||
| Repayments of term debt | (7,914) | (4,009) | |||||||||
| Repayments of commercial paper, net | (5,911) | (3,968) | |||||||||
| Other | (126) | (77) | |||||||||
| Cash used in financing activities | (61,935) | (68,377) | |||||||||
| Increase/(Decrease) in cash, cash equivalents, and restricted cash and cash equivalents | 9,638 | (1,781) | |||||||||
Cash, cash equivalents, and restricted cash and cash equivalents, ending balances | $ | 45,572 | $ | 28,162 | |||||||
| Supplemental cash flow disclosure: | |||||||||||
| Cash paid for income taxes, net | $ | 20,397 | $ | 31,683 | |||||||
Consolidated Statements of Comprehensive Income
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||
| March 28, 2026 | March 29, 2025 | March 28, 2026 | March 29, 2025 | ||||||||||||||||||||
| Net income | $ | 29,578 | $ | 24,780 | $ | 71,675 | $ | 61,110 | |||||||||||||||
| Other comprehensive income/(loss): | |||||||||||||||||||||||
| Change in foreign currency translation, net of tax | 67 | 90 | (92) | (535) | |||||||||||||||||||
| Change in unrealized gains/losses on derivative instruments, net of tax: | |||||||||||||||||||||||
| Change in fair value of derivative instruments | 162 | (318) | 373 | 1,333 | |||||||||||||||||||
| Adjustment for net (gains)/losses realized and included in net income | 44 | (628) | 281 | 156 | |||||||||||||||||||
| Total change in unrealized gains/losses on derivative instruments | 206 | (946) | 654 | 1,489 | |||||||||||||||||||
| Change in unrealized gains/losses on marketable debt securities, net of tax: | |||||||||||||||||||||||
| Change in fair value of marketable debt securities | (808) | 1,097 | (384) | (550) | |||||||||||||||||||
| Adjustment for net (gains)/losses realized and included in net income | 14 | 185 | 18 | 405 | |||||||||||||||||||
| Total change in unrealized gains/losses on marketable debt securities | (794) | 1,282 | (366) | (145) | |||||||||||||||||||
| Total other comprehensive income/(loss) | (521) | 426 | 196 | 809 | |||||||||||||||||||
| Total comprehensive income | $ | 29,057 | $ | 25,206 | $ | 71,871 | $ | 61,919 | |||||||||||||||
Notes to Financials
Note 1: Summary of Significant Accounting Policies
Boilerplate only. Nothing of substance to surface.
Note 2: Revenue
- Deferred revenue recognized: The portion of total net sales included in deferred revenue as of the beginning of the period was $4B (three months ended March 28, 2026) and $5.8B (six months ended March 28, 2026), versus $3.7B and $5.4B in the comparable prior-year periods.
- Deferred revenue balance: Total deferred revenue was $14.7B as of March 28, 2026, up from $13.7B as of September 27, 2025; of the March 28, 2026 balance, 64% is expected to be realized in less than a year, 23% within one-to-two years, 11% within two-to-three years, and 2% in greater than three years.
- Geographic mix note: The proportion of net sales by revenue source was generally consistent across reportable segments, except in Greater China, where iPhone revenue represented a moderately higher proportion of net sales.
in millions
Three Months Ended March 28, 2026
Three Months Ended March 29, 2025
| Segment | Three Months Ended March 28, 2026 | Three Months Ended March 29, 2025 | YoY |
|---|---|---|---|
| iPhone | $56,994 | $46,841 | +21.7% |
| Mac | $8,399 | $7,949 | +5.7% |
| iPad | $6,914 | $6,402 | +8.0% |
| Wearables, Home and Accessories | $7,901 | $7,522 | +5.0% |
| Services | $30,976 | $26,645 | +16.3% |
| Total | $111,184 | $95,359 | +16.6% |
Note 3: Earnings Per Share
in —
| Line item | Three Months Ended March 28, 2026 | Three Months Ended March 29, 2025 | YoY |
|---|---|---|---|
| Net income (millions) | 29,578 | 24,780 | +19.4% |
| Weighted-average basic shares outstanding (thousands) | 14,673,278 | 14,994,082 | -2.1% |
| Effect of dilutive share-based awards (thousands) | 52,595 | 62,051 | -15.2% |
| Weighted-average diluted shares (thousands) | 14,725,873 | 15,056,133 | -2.2% |
| Basic earnings per share | 2.02 | 1.65 | +22.4% |
| Diluted earnings per share | 2.01 | 1.65 | +21.8% |
Note 4: Financial Instruments
- Portfolio size and composition: Total cash, cash equivalents, and marketable securities had a fair value of $146.6B as of March 28, 2026 (adjusted cost $149.4B), up from $132.4B (adjusted cost $134.7B) as of September 27, 2025; the portfolio carries net unrealized losses of $3.2B at period-end versus $3B at fiscal year-end, with corporate debt securities ($47.2B fair value) and mortgage- and asset-backed securities ($23.9B fair value) the two largest Level 2 categories.
- Non-current securities maturity profile: As of March 28, 2026, 79% of non-current marketable debt securities other than mortgage- and asset-backed securities had maturities between 1 and 5 years, 17% between 5 and 10 years, and 4% greater than 10 years; for non-current mortgage- and asset-backed securities, 13% had maturities between 1 and 5 years, 22% between 5 and 10 years, and 65% greater than 10 years.
- Derivative notional exposure: Designated foreign exchange contracts stood at $58B (vs. $62.6B at September 27, 2025) and designated interest rate contracts at $10.6B (vs. $12.9B); undesignated foreign exchange contracts were $96.3B (vs. $109.1B); the carrying amount of term debt subject to fair value hedges was $10.4B as of March 28, 2026 versus $12.6B at September 27, 2025; the maximum hedge tenor for term debt-related foreign currency cash flow variability is 16 years.
- Receivables concentration: One trade receivable customer represented 17% of total trade receivables as of March 28, 2026 (12% at September 27, 2025); third-party cellular network carriers accounted for 30% (34% prior year-end); two vendors each represented 10% or more of vendor non-trade receivables, accounting for 51% and 18% as of March 28, 2026 (46% and 23% at September 27, 2025).
in millions
| Line item | March 28, 2026 | September 27, 2025 | YoY |
|---|---|---|---|
| Cash | 29,740 | 28,267 | +5.2% |
| Money market funds | 6,588 | 5,272 | +25.0% |
| Mutual funds | 935 | 854 | +9.5% |
| U.S. Treasury securities | 18,410 | 15,848 | +16.2% |
| U.S. agency securities | 7,371 | 5,120 | +44.0% |
| Non-U.S. government securities | 5,458 | 6,273 | -13.0% |
| Certificates of deposit and time deposits | 3,263 | 917 | +255.8% |
| Commercial paper | 3,628 | 100 | +3528.0% |
| Corporate debt securities | 47,212 | 46,560 | +1.4% |
| Municipal securities | 121 | 205 | -41.0% |
| Mortgage- and asset-backed securities | 23,869 | 23,004 | +3.8% |
Note 5: Condensed Consolidated Financial Statement Details
- Property, plant and equipment: Gross PP&E was $127.6B as of March 28, 2026 (vs. $125.8B as of September 27, 2025), with accumulated depreciation of ($77.4B) and ($76B) respectively, yielding net PP&E of $50.1B and $49.8B.
- Intangible assets: Gross intangible assets rose sharply to $37.8B as of March 28, 2026 from $24.9B as of September 27, 2025; after accumulated amortization of ($12B), net intangibles were $25.8B, of which $4.5B is classified as current and $21.3B as non-current (vs. $2.2B current and $11.1B non-current at September 27, 2025).
Note 6: Debt
- Commercial paper outstanding: As of March 28, 2026 and September 27, 2025, the Company had $2B and $8B of commercial paper outstanding, respectively, issued as unsecured short-term promissory notes for general corporate purposes including dividends and share repurchases.
- Commercial paper repayments: For the six months ended March 28, 2026, total repayments of commercial paper, net were ($5.9B), comprising ($2.1B) for maturities 90 days or less and ($3.8B) for maturities greater than 90 days; for the six months ended March 29, 2025, total repayments were ($4B), all from maturities 90 days or less.
- Term debt carrying amount: As of March 28, 2026 and September 27, 2025, the Company had outstanding fixed-rate notes with an aggregate carrying amount of $82.7B and $90.7B, respectively.
- Term debt fair value: Based on Level 2 inputs, the fair value of the Notes was $70.8B as of March 28, 2026 and $80.4B as of September 27, 2025, both at a discount to carrying value.
in millions
| Line item | Six Months Ended March 28, 2026 | Six Months Ended March 29, 2025 | YoY |
|---|---|---|---|
| Repayments of commercial paper, net (maturities 90 days or less) | (2,123) | (3,968) | -46.5% |
| Repayments of commercial paper (maturities greater than 90 days) | (3,788) | 0 | — |
Note 7: Shareholders’ Equity
- Share repurchases: During the six months ended March 28, 2026, the Company repurchased 135 million shares of its common stock for $36B under its share repurchase program, which does not obligate the Company to acquire a minimum amount of shares; repurchases may occur in privately negotiated or open market transactions, including under plans complying with Rule 10b5-1 under the Exchange Act.
Note 8: Share-Based Compensation
- RSU activity: The RSU balance grew from 151,574 thousand units (weighted-average grant-date fair value of $189.75) as of September 27, 2025 to 173,985 thousand units ($217.51) as of March 28, 2026, reflecting 66,083 thousand RSUs granted at $256.04, 37,502 thousand vested at $174.38, and 6,170 thousand forfeited at $210.31.
- Vesting-date fair value: Total vesting-date fair value of RSUs was $917M and $906M for the three months ended March 28, 2026 and March 29, 2025, respectively, and $9.5B and $9.3B for the six months ended March 28, 2026 and March 29, 2025, respectively.
- Unrecognized compensation cost: As of March 28, 2026, total unrecognized compensation cost related to outstanding RSUs was $28.8B, expected to be recognized over a weighted-average period of 2.8 years.
in millions
| Line item | Three Months Ended March 28, 2026 | Three Months Ended March 29, 2025 | YoY |
|---|---|---|---|
| Share-based compensation expense | 3,528 | 3,226 | +9.4% |
| Income tax benefit related to share-based compensation expense | (802) | (743) | +7.9% |
Note 9: Commitments and Contingencies
Commitments
- Unconditional purchase obligations ($27.7B total, as of March 28, 2026): Supplier arrangements, distribution rights, and licensed intellectual property and content; payments of $2,994M (remaining 2026), $7,343M (2027), $6,130M (2028), $5,394M (2029), $5,281M (2030), and $549M thereafter.
Legal Proceedings
- General litigation contingencies: Management opines there was not at least a reasonable possibility the Company incurred a material loss, or a material loss greater than a recorded accrual, for asserted legal and other claims.
Note 10: Segment Information
- Segment structure: The company reports 5 geographic reportable segments — Americas, Europe, Greater China, Japan, and Rest of Asia Pacific — plus a Corporate segment that captures Research and development and General and administrative expenses not allocated to the geographic segments.
- Corporate allocation: Selling and marketing costs are allocated to the geographic segments; R&D and G&A are reported entirely within Corporate, resulting in an operating loss at the Corporate level ($13.7B for the three months ended March 28, 2026 vs. $10.5B for the three months ended March 29, 2025).
in millions
| Line item | Three Months Ended March 28, 2026 | Three Months Ended March 29, 2025 | YoY |
|---|---|---|---|
| Americas — Net sales | 45,093 | 40,315 | +11.9% |
| Americas — Cost of sales | (23,114) | (21,094) | +9.6% |
| Americas — Selling and marketing | (2,606) | (2,447) | +6.5% |
| Americas — Operating income | 19,373 | 16,774 | +15.5% |
| Europe — Net sales | 28,055 | 24,454 | +14.7% |
| Europe — Cost of sales | (13,756) | (13,025) | +5.6% |
| Europe — Selling and marketing | (1,247) | (1,113) | +12.0% |
| Europe — Operating income | 13,052 | 10,316 | +26.5% |
| Greater China — Net sales | 20,497 | 16,002 | +28.1% |
| Greater China — Cost of sales | (10,633) | (8,794) | +20.9% |
| Greater China — Selling and marketing | (675) | (582) | +16.0% |
| Greater China — Operating income | 9,189 | 6,626 | +38.7% |
| Japan — Net sales | 8,401 | 7,298 | +15.1% |
| Japan — Cost of sales | (4,267) | (3,610) | +18.2% |
| Japan — Selling and marketing | (295) | (254) | +16.1% |
| Japan — Operating income | 3,839 | 3,434 | +11.8% |
| Rest of Asia Pacific — Net sales | 9,138 | 7,290 | +25.3% |
| Rest of Asia Pacific — Cost of sales | (4,633) | (3,969) | +16.7% |
| Rest of Asia Pacific — Selling and marketing | (378) | (335) | +12.8% |
| Rest of Asia Pacific — Operating income | 4,127 | 2,986 | +38.2% |
| Corporate — Research and development | (11,419) | (8,550) | +33.6% |
| Corporate — General and administrative | (2,276) | (1,997) | +14.0% |
| Corporate — Operating loss | (13,695) | (10,547) | +29.8% |
Management Discussion & Analysis
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Boilerplate only. Nothing of substance to surface.
Available Information
Boilerplate only. Nothing of substance to surface.
Business Seasonality and Product Introductions
- Seasonal pattern: The Company has historically experienced higher net sales in its first quarter compared to other quarters due in part to seasonal holiday demand.
- Channel dynamics: New product introductions can significantly impact net sales, cost of sales, and operating expenses; indirect distribution channel inventory fills with new inventory following a launch while older product channel inventory often declines as a newer launch approaches, and net sales can also be affected when consumers and distributors anticipate a product introduction.
- Q2 2026 launches: During the second quarter of 2026, the Company announced the following new or updated products: iPad Air®, iPhone 17e, MacBook Pro®, MacBook Air®, MacBook Neo™, and AirPods Max® 2.
Macroeconomic Conditions
- Macroeconomic headwinds: Inflation, interest rates, component pricing, and currency fluctuations have directly and indirectly impacted, and could in the future materially impact, the Company's results of operations and financial condition.
- Supply constraints intensifying: The Company is experiencing supply constraints and increasing costs for components driven by industry supply-demand imbalances, including advanced semiconductors, storage (NAND), and memory (DRAM); the Company expects these trends to intensify, which — together with any responsive actions taken — may materially adversely affect demand for the Company's products and negatively impact revenue, costs, gross margin, results of operations, and financial condition.
Tariffs and Other Measures
- Tariff landscape: Beginning in Q2 2025, new U.S. tariffs were announced on imports from China, India, Japan, South Korea, Taiwan, Vietnam, and the EU, with several countries imposing or threatening reciprocal tariffs and other retaliatory measures.
- Section 232 investigation: On January 14, 2026, initial results of the U.S. Department of Commerce's Section 232 investigation into semiconductors, semiconductor manufacturing equipment, and derivative/downstream products were published; the announcement did not impose any additional tariffs affecting the Company's products.
- Supreme Court ruling and refund claim: On February 20, 2026, the U.S. Supreme Court struck down certain tariffs previously imposed under the International Emergency Economic Powers Act of 1977, and the Company is applying for a refund of tariffs paid through U.S. Customs and Border Protection processes.
- Residual uncertainty: The Company states tariffs and related measures can have a material adverse impact on its business, results of operations, and financial condition — including supply chain, availability of rare earths and other raw materials and components, pricing, and gross margin — with the ultimate impact depending on whether additional U.S. tariffs are imposed, the scope of foreign retaliatory measures, and the overall magnitude and duration of such measures.
Segment Operating Performance
in millions
By Region
Three Months Ended March 28, 2026
Three Months Ended March 29, 2025
| Segment | Three Months Ended March 28, 2026 | Three Months Ended March 29, 2025 | YoY |
|---|---|---|---|
| Americas | $45,093 | $40,315 | +11.9% |
| Europe | $28,055 | $24,454 | +14.7% |
| Greater China | $20,497 | $16,002 | +28.1% |
| Japan | $8,401 | $7,298 | +15.1% |
| Total | $102,046 | $88,069 | +15.9% |
By Business Segment
Three Months Ended March 28, 2026
Three Months Ended March 29, 2025
| Segment | Three Months Ended March 28, 2026 | Three Months Ended March 29, 2025 | YoY |
|---|---|---|---|
| Rest of Asia Pacific | $9,138 | $7,290 | +25.3% |
| Total | $9,138 | $7,290 | +25.3% |
Americas
- Revenue drivers: Americas net sales increased during the second quarter and first six months of 2026 compared to the same periods in 2025 due to higher net sales of iPhone and Services.
- FX impact: The strength in foreign currencies relative to the U.S. dollar had a favorable year-over-year impact on Americas net sales during the second quarter of 2026.
Europe
- Revenue drivers: Europe net sales increased during the second quarter and first six months of 2026 compared to the same periods in 2025 primarily due to higher net sales of iPhone and Services.
- FX impact: The strength in foreign currencies relative to the U.S. dollar had a net favorable year-over-year impact on Europe net sales during both the second quarter and first six months of 2026.
Greater China
- iPhone drove growth: Greater China net sales increased in both the second quarter and first six months of 2026 compared to the same periods in 2025, driven by higher net sales of iPhone.
- Currency tailwind: The strength of the renminbi relative to the U.S. dollar had a favorable year-over-year impact on Greater China net sales during the second quarter of 2026.
Japan
- Revenue driver: Japan net sales increased during the second quarter and first six months of 2026 compared to the same periods in 2025 primarily due to higher net sales of iPhone.
- Currency headwind: The weakness in the yen relative to the U.S. dollar had an unfavorable year-over-year impact on Japan net sales during the first six months of 2026.
Rest of Asia Pacific
- Revenue drivers: Rest of Asia Pacific net sales increased during the second quarter and first six months of 2026 compared to the same periods in 2025 primarily due to higher net sales of iPhone and Services.
- FX impact: The strength in foreign currencies relative to the U.S. dollar had a net favorable year-over-year impact on Rest of Asia Pacific net sales during the second quarter of 2026.
Products and Services Performance
in millions
Three Months Ended March 28, 2026
Three Months Ended March 29, 2025
| Segment | Three Months Ended March 28, 2026 | Three Months Ended March 29, 2025 | YoY |
|---|---|---|---|
| iPhone | $56,994 | $46,841 | +21.7% |
| Mac | $8,399 | $7,949 | +5.7% |
| iPad | $6,914 | $6,402 | +8.0% |
| Wearables, Home and Accessories | $7,901 | $7,522 | +5.0% |
| Services | $30,976 | $26,645 | +16.3% |
| Total | $111,184 | $95,359 | +16.6% |
iPhone
Revenue driver: iPhone net sales increased during both the second quarter and first six months of 2026 compared to the same periods in 2025, driven by higher net sales of Pro models.
Mac
- Quarterly performance: Mac net sales increased in the second quarter of 2026 compared to the second quarter of 2025, driven by higher net sales of laptops.
- Year-to-date performance: Mac net sales during the first six months of 2026 were relatively flat year-over-year.
Wearables, Home and Accessories
- Q2 2026 drivers: Wearables, Home and Accessories net sales increased during the second quarter of 2026 compared to the second quarter of 2025 primarily due to higher net sales of Accessories and Wearables.
- Year-to-date trend: Year-over-year Wearables, Home and Accessories net sales during the first six months of 2026 were relatively flat.
Services
- Revenue drivers: Services net sales increased during both the second quarter and first six months of 2026 compared to the same periods in 2025, primarily due to higher net sales from advertising, the App Store®, and cloud services.
Gross Margin
- Products gross margin %: Products gross margin percentage expanded 280 basis points year-over-year to 38.7% for the three months ended March 28, 2026 (versus 35.9% in the prior-year period) and expanded 200 basis points to 39.9% for the six months ended March 28, 2026 (versus 37.9%).
- Services gross margin %: Services gross margin percentage expanded 100 basis points to 76.7% for the three months ended March 28, 2026 (versus 75.7%) and expanded 120 basis points to 76.6% for the six months ended March 28, 2026 (versus 75.4%).
- Total gross margin %: Total gross margin percentage rose to 49.3% for the three months ended March 28, 2026 (from 47.1%) and to 48.6% for the six months ended March 28, 2026 (from 47.0%).
Gross Margin — Three Months Ended
in millions
| Line item | March 28, 2026 | March 29, 2025 | YoY |
|---|---|---|---|
| Products | 31,029 | 24,684 | +25.7% |
| Services | 23,752 | 20,183 | +17.7% |
Gross Margin — Six Months Ended
in millions
| Line item | March 28, 2026 | March 29, 2025 | YoY |
|---|---|---|---|
| Products | 77,294 | 63,197 | +22.3% |
| Services | 46,718 | 39,945 | +17.0% |
Products Gross Margin
- Products gross margin: Increased during both the second quarter and first six months of 2026 compared to the same periods in 2025, driven primarily by a different mix of products and strength in foreign currencies relative to the U.S. dollar, partially offset by higher costs.
Services Gross Margin
- Services gross margin (dollars): Increased in both the second quarter and first six months of 2026 compared to the same periods in 2025, primarily due to higher Services net sales and a different mix of services.
- Services gross margin %: Increased in both periods primarily due to a different mix of services and strength in foreign currencies relative to the U.S. dollar, partially offset by higher costs.
- Forward outlook: The Company believes gross margins will generally be subject to volatility and downward pressure.
Operating Expenses
- R&D growth: Research and development expense rose 34% to $11.4B in the three months ended March 28, 2026 (vs. $8.6B in the prior-year quarter), and 33% to $22.3B for the six months ended March 28, 2026 (vs. $16.8B), with R&D as a percentage of total net sales increasing to 10% from 9% on a quarterly basis and to 9% from 8% on a six-month basis.
- SG&A growth: Selling, general and administrative expense increased 11% to $7.5B in the three months ended March 28, 2026 (vs. $6.7B), and 8% to $15B for the six months ended March 28, 2026 (vs. $13.9B), with SG&A holding steady at 7% of total net sales on a quarterly basis and 6% on a six-month basis.
- Total operating expenses: Combined operating expenses grew 24% to $18.9B for the three months ended March 28, 2026 (vs. $15.3B) and 21% to $37.3B for the six months ended March 28, 2026 (vs. $30.7B), representing 17% and 15% of total net sales, respectively, versus 16% and 14% in the prior-year comparable periods.
in millions
| Line item | Three Months Ended March 28, 2026 | Three Months Ended March 29, 2025 | YoY |
|---|---|---|---|
| Research and development | 11,419 | 8,550 | +33.6% |
| Selling, general and administrative | 7,477 | 6,728 | +11.1% |
Research and Development
- R&D expense drivers: R&D expense increased during the second quarter and first six months of 2026 compared to the same periods in 2025 primarily due to higher infrastructure-related costs and headcount-related expenses.
Selling, General and Administrative
- Drivers of increase: Selling, general and administrative expense increased during the second quarter and first six months of 2026 compared to the same periods in 2025 primarily due to higher headcount-related expenses, variable selling expenses, and professional services.
Provision for Income Taxes
- Effective tax rate vs. statutory rate: The effective tax rate of 17.5% for both the three and six months ended March 28, 2026 was below the 21% statutory federal rate, primarily due to a lower effective tax rate on foreign earnings and the U.S. federal R&D credit; tax benefits from share-based compensation also contributed for the six-month period, while state income taxes partially offset these benefits in both periods.
- Year-over-year rate increase: The effective tax rate rose to 17.5% in Q2 2026 from 15.5% in Q2 2025, and to 17.5% for the six months ended March 28, 2026 from 15.0% for the same period in 2025, primarily due to changes in unrecognized tax benefits; the six-month comparison was further affected by foreign currency loss regulations issued by the U.S. Department of the Treasury in December 2024 and tax impacts from foreign currency revaluations in Q1 2025 related to the State Aid Decision.
- Provision dollars: Provision for income taxes was $6.3B in the three months ended March 28, 2026 (vs. $4.5B in the three months ended March 29, 2025) and $15.2B for the six months ended March 28, 2026 (vs. $10.8B for the six months ended March 29, 2025).
in millions
| Line item | Three Months Ended March 28, 2026 | Three Months Ended March 29, 2025 | YoY |
|---|---|---|---|
| Provision for income taxes | 6,255 | 4,530 | +38.1% |
| Effective tax rate (%) | 17.50 | 15.50 | +12.9% |
| Statutory federal income tax rate (%) | 21 | 21 | +0.0% |
Liquidity and Capital Resources
- Liquidity adequacy: The Company believes its balances of cash, cash equivalents and marketable securities, along with cash generated by ongoing operations and continued access to debt markets, will be sufficient to satisfy its cash requirements and capital return program over the next 12 months and beyond.
- Contractual cash requirements: The Company's contractual cash requirements have not changed materially since the 2025 Form 10-K, except for manufacturing purchase obligations, other purchase obligations, and deemed repatriation tax payable.
Manufacturing Purchase Obligations
- Manufacturing purchase obligations: As of March 28, 2026, the Company had manufacturing purchase obligations of $44.6B, with $43.9B payable within 12 months, reflecting the Company's use of outsourcing partners for subassembly manufacturing, final assembly and testing, and a wide variety of individual component suppliers.
Other Purchase Obligations
- Composition: Other purchase obligations consist of noncancelable obligations related to supplier arrangements, licensed intellectual property and content, distribution rights, and the acquisition of capital assets related to product manufacturing.
- Outstanding obligations: As of March 28, 2026, total other purchase obligations were $30.4B, of which $9.3B is payable within 12 months.
Deemed Repatriation Tax Payable
Deemed repatriation tax: During the first six months of 2026, the Company paid the remaining $8.8B balance of the deemed repatriation tax payable imposed by the U.S. Tax Cuts and Jobs Act of 2017.
Capital Return Program
- Share repurchase authorization: As of March 28, 2026, remaining availability under the existing share repurchase program was $63.8B; on April 30, 2026, the Board authorized an additional program to repurchase up to $100B of common stock, with neither program obligating the Company to acquire a minimum amount of shares.
- Dividend increase: On April 30, 2026, the Board raised the quarterly cash dividend from $0.26 to $0.27 per share, beginning with the dividend to be paid during the third quarter of 2026; the Company intends to increase its dividend on an annual basis, subject to Board declaration.
- Q2 2026 capital returns: During the second quarter of 2026, the Company repurchased $11B of its common stock and paid dividends and dividend equivalents of $3.8B.
Recent Accounting Pronouncements
Internal-Use Software
Boilerplate only. Nothing of substance to surface.
Disaggregation of Income Statement Expenses
Boilerplate only. Nothing of substance to surface.
Income Taxes
Boilerplate only. Nothing of substance to surface.
Critical Accounting Estimates
Boilerplate only. Nothing of substance to surface.
More AAPL Smart Summaries
Other filings for Apple Inc. with a Smart Summary.
Never miss a AAPL filing
Get real-time email alerts when AAPL files with the SEC.